Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition and method conducive to acquiring follicular regulatory T cells in vitro and application of composition

A composition and regulatory technology, applied in the direction of biochemical equipment and methods, animal cells, vertebrate cells, etc.

Active Publication Date: 2017-09-19
ZHONGSHAN HOSPITAL FUDAN UNIV
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, baicalin has not been found to promote Foxp3 + Related reports on Tfr differentiation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition and method conducive to acquiring follicular regulatory T cells in vitro and application of composition
  • Composition and method conducive to acquiring follicular regulatory T cells in vitro and application of composition
  • Composition and method conducive to acquiring follicular regulatory T cells in vitro and application of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] 1. Materials

[0033] MRL / lpr lupus mice: purchased from Shanghai Slack Experimental Animal Co., Ltd.

[0034] anti-CD3 / CD28 activated magnetic beads: purchased from Peprotech.

[0035] TGF-β: purchased from Peprotech, Cat. No. AF-100-21C.

[0036] IL-2: purchased from Peprotech Company, article number AF-212-12.

[0037] Baicalin: purchased from Tongtian Biology, dissolved in DMSO and prepared into solutions with different concentrations of 10 μM, 20 μM and 40 μM.

[0038]2. Methods and Results

[0039] 1. Baicalin combined with cytokines promotes the proliferation of Tfr cells:

[0040] Mononuclear cells were sorted from the spleen of MRL / lpr lupus mice, and naive T cells were sorted by immunomagnetic beads and cultured in vitro. On day 0, the sorted 2×10 6 naive CD4 + T cells were resuspended in a 24-well plate, the culture medium was RPMI1640 medium containing 10% fetal bovine serum, and anti-CD3 / CD28 activated magnetic beads (25 μl, the final concentration o...

Embodiment 2

[0048] To investigate the effects of different induction conditions on the proliferation of Tfr cells and the differentiation of naive T cells into Tfr.

[0049] 1. Materials

[0050] MRL / lpr lupus mice: purchased from Shanghai Slack Experimental Animal Co., Ltd.

[0051] anti-CD3 / CD28 activated magnetic beads: purchased from Peprotech.

[0052] TGF-β: purchased from Peprotech, Cat. No. AF-100-21C.

[0053] IL-2: purchased from Peprotech Company, article number AF-212-12.

[0054] Baicalin: purchased from Tongtian Biology, dissolved in DMSO and prepared into a solution of corresponding concentration.

[0055] 2. Method

[0056] 1. Group settings

[0057] The groups are shown in Table 1.

[0058] Table 1 Experimental grouping

[0059] group

[0060] 2. The proliferation of Tfr cells in different groups

[0061] Mononuclear cells were sorted from the spleen of MRL / lpr lupus mice, and naive T cells were sorted by immunomagnetic beads and cultured in vitro. On d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a composition and a method conducive to acquiring follicular regulatory T cells in vitro and an application of the composition. The invention proves that differentiation and number proliferation of in-vitro Tfr (follicular regulatory T cells) can be effectively induced by the aid of irritation of TGF (transforming growth factor)-beta, IL (interleukin)-2, anti-CD3 antibodies, anti-CD28 antibodies and baicalin, and expression of Foxp3 in the Tfr is facilitated. The Tfr cells amplified by the method can be used for treating autoimmune diseases and chronic inflammatory diseases, the autoimmune diseases include lupus erythematosus, dermatomyositis, vasculitides, sicca syndrome, scleroderma, rheumatoid arthritis, ankylosing spondylitis, disseminated sclerosis and autoimmune hepatitis, and the chronic inflammatory diseases include diabetes, coronary heart diseases, hyperlipemia, eczema, vitiligos, atopic dermatitis, lichen planus and the like.

Description

technical field [0001] The present invention relates to inducing differentiation to obtain follicular regulatory T cells in vitro, in particular to a composition, method and application for obtaining follicular regulatory T cells in vitro. Background technique [0002] Follicular regulatory T cells (Tfr), surface marker CD4 + CXCR5 + , the transcription factors are Foxp3 and BCL-6, which are a group of T cells with immune regulation function existing in the germinal center and peripheral blood. Tfr derived from Foxp3 + In natural regulatory T cells (nTreg), Tfr can exert contact inhibition through CTLA-4 on the cell membrane surface, and can also stimulate follicular helper T cells and B cells through secreted cytokines IL-10, TGF-β or perforin. Cells play an immunosuppressive role, inhibit the formation of germinal centers, autoantibody secretion, and control the hyperactivity of humoral immunity; Tfr can also inhibit the proliferation and secretion of other effector T c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0783
CPCC12N5/0637C12N2500/30C12N2501/2302C12N2501/51C12N2501/515
Inventor 杨骥李明
Owner ZHONGSHAN HOSPITAL FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com